2017
DOI: 10.1590/1516-4446-2017-2299
|View full text |Cite
|
Sign up to set email alerts
|

Plasma IL-17A levels in patients with late-life depression

Abstract: Objective: A consistent body of research has confirmed that patients with major depressive disorder (MDD) have increased concentrations of pro-inflammatory cytokines, including IL-6, TNF-a, IL-1b, the soluble IL-2 receptor, and C-reactive protein, compared to controls; however, there is limited information on IL-17A in MDD. Moreover, information about IL-17A in older populations, i.e., patients with late-life depression (LLD), is conspicuously missing from the literature. The purpose of this study was to inves… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 21 publications
0
14
0
Order By: Relevance
“…One study found a decrease in the number of T H 17 cells in depressed subjects compared to age and gender-matched healthy controls, but also found a decrease in the number of T reg cells from depressed subjects when the sample was restricted to those over 28 years of age (Grosse et al, 2016). Others have found no differences in plasma levels of IL-17A between a group with late-life depression and a group of healthy matched controls (Saraykar et al, 2017), or a decreased level of IL-17A in patients with recurrent depressive disorder (Rybka, 2013). This seemingly contradictory literature, in both animals and humans, may perhaps be explained by differences between acute depressive symptoms and those of chronic depression, which some have posited represent two different states of immune regulation, with activation at the time of acute symptoms and suppression in the face of chronic symptoms (Hong et al, 2013).…”
Section: Depressionmentioning
confidence: 95%
“…One study found a decrease in the number of T H 17 cells in depressed subjects compared to age and gender-matched healthy controls, but also found a decrease in the number of T reg cells from depressed subjects when the sample was restricted to those over 28 years of age (Grosse et al, 2016). Others have found no differences in plasma levels of IL-17A between a group with late-life depression and a group of healthy matched controls (Saraykar et al, 2017), or a decreased level of IL-17A in patients with recurrent depressive disorder (Rybka, 2013). This seemingly contradictory literature, in both animals and humans, may perhaps be explained by differences between acute depressive symptoms and those of chronic depression, which some have posited represent two different states of immune regulation, with activation at the time of acute symptoms and suppression in the face of chronic symptoms (Hong et al, 2013).…”
Section: Depressionmentioning
confidence: 95%
“…There are several studies showing that IL-17A levels are not associated with depressive symptoms (Liu et al, 2012;Kim et al, 2013;Spanemberg et al, 2014). For example, Saraykar hypothesized that there is no correlation between IL-17A and depression in late life, but there is a possible association between IL-17A and cognitive dysfunction (Saraykar et al, 2018). This could suggest that Th17 cells may exert their effects in depression via cytokines other than IL-17, such as IL-21 and IL-22.…”
Section: Th17 Cells and Depressionmentioning
confidence: 99%
“…The notion that Th17 cells play a critical role in the onset of depression has been growing in popularity but remains controversial. Several human studies have demonstrated that changes in IL-17 are correlated with depression 21,23,25,51 while others have not 20,24 . While further work is needed to fully understand the role of IL-17 in the onset of depressive symptoms, our work demonstrates that the AHR is not responsible for the observed stress-induced increase in intestinal Th17s and that these cells are not necessary for the induction of stress-induced depression.…”
Section: Discussionmentioning
confidence: 99%
“…Administration of IL-17A blocking antibodies has also been found to reduce learned helplessness behaviors in mice 17 . However, the evidence for the role of IL-17 in human depression remains controversial, with some reports claiming a positive correlation between the inflammatory cytokine and depression and others reporting no differences in IL-17 levels between those with the disease and controls [20][21][22][23][24][25] . These conflicting results highlight the need for further investigation into the mechanism and role of the AHR and increased inflammatory Th17 cells in depression.…”
Section: Introductionmentioning
confidence: 99%